시장보고서
상품코드
2095234

방문 진료 시장 : 시장 예측(2026-2032년)

House Calls Market - Global Forecast 2026-2032

발행일: | 리서치사: 구분자 360iResearch | 페이지 정보: 영문 189 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF, Excel & 1 Year Online Access (1-5 Users License) help
PDF & Excel 보고서를 동일 기업내 5명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있을 뿐만 아니라, 정기적으로 업데이트되는 정보에 접근할 수 있습니다.
US $ 3,939 금액 안내 화살표 ₩ 5,745,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF & Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다. 온라인 플랫폼에서 1년 동안 보고서를 무제한으로 다운로드할 수 있을 뿐만 아니라, 정기적으로 업데이트되는 정보에 접근할 수 있습니다.
US $ 5,959 금액 안내 화살표 ₩ 8,691,000
※ 부가세 별도
한글목차
영문목차

방문 진료 시장은 2032년까지 연평균 복합 성장률(CAGR) 9.08%로 성장이 전망되며, 143억 4,000만 달러 규모로 확대될 것으로 예측됩니다.

주요 시장 통계
기준 연도 : 2025년 78억 달러
추정 연도 : 2026년 84억 9,000만 달러
예측 연도 : 2032년 143억 4,000만 달러
CAGR(%) 9.08%

방문 진료는 고령화, 만성 질환 관리 수요, 급성기 후 케어 수요, 그리고 집에서 받을 수 있는 편리한 케어를 선호하는 소비자 경향에 힘입어, 환자 중심의 의료 제공을 위한 핵심 모델로서 다시 주목받고 있습니다. 현대적인 방문 진료 서비스는 기존의 의사 진찰에 그치지 않고, 전문 간호사(Nurse Practitioner)에 의한 간호, 재택 응급 치료, 노인 의학적 평가, 완화 의료, 재활 지원, 진단, 복약 관리, 행동 건강 관련 간호, 그리고 원격 환자 모니터링 등을 포괄하고 있습니다. 이러한 변화는 널리 보고되고 있는 의료 시스템의 우선순위와 일치합니다. 구체적으로는 예방 가능한 응급실 이용 감소, 치료의 연속성 향상, ‘재택 병원’으로의 전환 경로 지원, 그리고 고령자나 복합적인 질환을 가진 환자의 이동·교통 수단·접근성과 관련된 장벽 해소 등을 들 수 있습니다. 방문 진료의 현황은 가치 기반 진료, 통합 진료 경로, 디지털 헬스 인프라, 그리고 의료 종사자 체계 재구축을 통해 점차 형성되고 있습니다. 고소득 국가에서는 재택 1차 진료 및 재택 급성기 치료 프로그램이 환자 경험을 향상시키고, 임상적으로 적절한 경우 시설 기반 치료에 대한 의존도를 줄일 수 있기 때문에 정책 입안자와 보험사의 주목을 받고 있습니다. 신흥 시장에서는 이동형 진료팀과 지역 의료 네트워크가 의사 부족 및 의료시설 접근성 격차로 인해 발생한 공백을 메우는 데 일조하고 있습니다. 모든 시장에서 임상 거버넌스, 상호 운용 가능한 의료 기록, 명확한 보상 체계, 그리고 신뢰할 수 있는 물류 체계가 융합되는 지점에서 가장 큰 기회가 발견되고 있습니다.

방문 진료를 재구성하는 혁신적인 변화

방문 진료 분야는 일회성 방문 진료에서 연계된 기술을 활용한 케어 생태계로 구조적인 변혁을 이루고 있습니다. 인구통계학적 압력이 주요 촉진요인으로 작용하고 있습니다. 전 세계적인 고령화에 따라 다중 질환, 허약, 인지 기능 장애, 이동 능력 제한이 증가하고 있으며, 이 모든 요인이 재택 돌봄 제공에 대한 임상적 근거를 강화하고 있습니다. 동시에 의료 시스템에서는 수용 능력 관리 개선, 재입원 감소, 그리고 익숙한 환경에서의 회복 지원을 목적으로 시설 기반 케어를 대체할 수 있는 대안이 우선시되고 있습니다.

인공지능이 방문 진료에 미치는 누적 영향

인공지능(AI)은 환자 선별, 돌봄 계획, 업무 효율, 기록의 질, 원격 모니터링을 개선함으로써 방문 진료에 누적 영향을 미치고 있습니다. AI를 활용한 위험도 계층화를 통해 빈번한 급성기 의료 이용, 복잡한 약물 관리, 낙상 위험, 만성 질환의 불안정성 또는 이동 능력 제한이 있는 환자 등 재택 간호에서 가장 큰 혜택을 받을 가능성이 높은 환자를 우선적으로 식별할 수 있습니다. 예측 분석은 피할 수 있는 상태 악화가 발생하기 전에 적극적인 아웃리치, 조기 개입 및 단계적 돌봄 강화를 지원할 수 있습니다.

방문 진료에 관한 주요 지역별 인사이트

아시아태평양에서는 급속한 인구 고령화, 도시 지역의 의료 과밀화, 디지털 헬스 확산, 그리고 농촌 지역의 의료 접근성 격차 확대가 맞물려 방문 진료가 추진되고 있습니다. 일본, 한국, 호주, 중국, 인도 및 아세안(ASEAN) 시장에서는 고령자 돌봄 및 만성 질환 관리부터 지역 밀착형 아웃리치 활동 및 원격 의료를 활용한 방문 진료에 이르기까지, 도입을 촉진하는 요인이 각각 다릅니다. '익숙한 곳에서 노후를 보내기' 위한 정책 지원, 원격 모니터링의 이용 확대, 하이브리드형 케어 모델에 대한 수용도 향상으로 인해 이 지역에서 재택치료 서비스의 장기적인 중요성은 더욱 높아지고 있습니다.

재택치료에 관한 주요 그룹 인사이트

NATO 회원국들은 북미 및 유럽의 의료 시스템과 크게 겹치며, 이러한 지역에서는 재택 돌봄이 회복탄력성, 집단건강관리, 그리고 돌봄의 연속성과 점점 더 밀접하게 연관되어 있습니다. 민간 의료의 현대화, 재향군인 및 국방 관련 의료 시스템, 그리고 비상사태 대비에 관한 고려 사항들은 모두 기존 시설 환경 밖에서도 기능할 수 있는 분산형 케어 모델의 가치를 뒷받침하고 있습니다.

방문 진료에 관한 주요 국가별 인사이트

미국은 가정 내 1차 진료, 만성 질환 관리, 완화 의료 및 가정 내 급성기 진료 모델에 대한 수요가 높기 때문에 방문 진료에 있어 유력한 시장으로 자리 잡고 있습니다. 가치 기반 의료 체계, 메디케어 관련 이니셔티브, 원격 환자 모니터링에 대한 보험 급여 경로, 그리고 퇴원 후 치료 수요가 도입을 촉진하고 있지만, 한편으로는 인력 부족과 주 차원의 복잡한 규제가 여전히 실무상의 제약 요인으로 작용하고 있습니다. 중국의 방문 진료 기회는 급속한 고령화, 높은 만성 질환 유병률, 병원 과밀화, 디지털 헬스 플랫폼의 확대와 관련이 있으나, 규제 표준화와 의료 제공업체의 질에 대한 신뢰가 필수적입니다. 독일에서는 고령화, 법정 보험 제도, 그리고 잘 갖춰진 외래 의료 부문이 체계적인 방문 진료의 기회를 창출하고 있지만, 인력 확보와 의료 제공업체 간의 협력이 중요한 과제로 대두되고 있습니다.

방문 진료 리더를 위한 실천적 제안

업계 리더는 복잡한 1차 진료, 노인 의학적 평가, 만성 질환 관리, 퇴원 후 사후 관리, 완화 의료, 재활 조정, 비응급 치료 등 재택치료가 측정 가능한 가치를 창출하는 임상적으로 적절한 서비스 분야를 우선시해야 합니다. 병원, 1차 진료 제공업체, 보험사, 장기 요양 시설, 지역 단체와의 견고한 의뢰 관계를 구축하는 것은 신뢰할 수 있는 환자 공급원을 확보하고 치료의 연속성을 향상시키기 위해 필수적입니다.

방문 진료 분석을 위한 조사 방법론

본 요약 보고서는 공개되고 검증 가능한 정보원 및 확립된 의료 부문의 인사이트를 바탕으로 한 2차 조사 접근법을 사용하여 작성되었습니다. 이 조사 방법론에서는 인구 동향, 의료 제공 정책, 디지털 헬스 도입 현황, 보상 구조, 만성 질환 부담, 고령화 지표, 원격의료 통합, 재택 및 지역 밀착형 돌봄 모델, 그리고 가치 기반·환자 중심 돌봄으로의 전환에 관한 실증 데이터가 고려되었습니다.

결론 : 방문 진료의 미래

의료 시스템이 기존 시설 밖에서 더 이용하기 쉽고, 연계가 잘되며, 환자 중심의 진료를 제공하기 위해 노력하는 가운데, 방문 진료는 현대 의료에서 점점 더 중요한 요소로 자리 잡고 있습니다. 고령화, 만성 질환 유병률, 병원 수용 능력의 한계, 소비자의 기대, 그리고 디지털 헬스의 성숙도 등의 요인이 복합적으로 작용하여 재택치료 서비스의 역할을 강화하고 있습니다. 이 모델은 더 이상 편의성을 중시하는 방문 진료에 그치지 않고, 예방, 급성기 의료의 대체, 급성기 후 회복, 완화 의료, 그리고 장기적인 질환 관리를 지원하는 임상적으로 통합된 접근 방식으로 진화하고 있습니다.

자주 묻는 질문

  • 방문 진료 시장의 규모와 성장률은 어떻게 예측되나요?
  • 방문 진료의 주요 요인은 무엇인가요?
  • 인공지능이 방문 진료에 미치는 영향은 무엇인가요?
  • 아시아태평양 지역에서 방문 진료가 추진되는 이유는 무엇인가요?
  • 미국의 방문 진료 시장의 특징은 무엇인가요?
  • 방문 진료 리더를 위한 실천적 제안은 무엇인가요?

목차

제1장 서문

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

제6장 AI의 누적 영향(2026년)

제7장 방문 진료 시장 : 서비스 형태별

제8장 방문 진료 시장 : 케어 제공 모델별

제9장 방문 진료 시장 : 임상 분야별

제10장 방문 진료 시장 : 프로바이더 유형별

제11장 방문 진료 시장 : 연령층별

제12장 방문 진료 시장 : 지역별

제13장 방문 진료 시장 : 그룹별

제14장 방문 진료 시장 : 국가별

제15장 경쟁 구도

제16장 기업 개요

AJY

The House Calls Market is projected to grow by USD 14.34 billion at a CAGR of 9.08% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.80 billion
Estimated Year [2026] USD 8.49 billion
Forecast Year [2032] USD 14.34 billion
CAGR (%) 9.08%

House calls are re-emerging as a core model of patient-centered healthcare delivery, supported by aging populations, chronic disease management needs, post-acute care demand, and consumer preference for convenient care at home. Modern house call services extend beyond traditional physician visits to include nurse practitioner care, urgent care at home, geriatric assessment, palliative care, rehabilitation support, diagnostics, medication management, behavioral health touchpoints, and remote patient monitoring. This shift aligns with widely documented health system priorities: reducing avoidable emergency department use, improving continuity of care, supporting hospital-at-home pathways, and addressing mobility, transportation, and access barriers for older adults and medically complex patients. The house calls landscape is increasingly shaped by value-based care, integrated care pathways, digital health infrastructure, and workforce redesign. In high-income countries, home-based primary care and acute care-at-home programs are gaining policy and payer attention because they can improve patient experience and reduce institutional care exposure when clinically appropriate. In emerging markets, mobile care teams and community health networks are helping bridge gaps created by physician shortages and uneven facility access. Across markets, the strongest opportunities are found where clinical governance, interoperable health records, reimbursement clarity, and reliable logistics converge.

Transformative Shifts Reshaping House Calls

The house calls sector is undergoing a structural transformation from episodic home visits to coordinated, technology-enabled care ecosystems. Demographic pressure is a major catalyst: global population aging is increasing the prevalence of multimorbidity, frailty, cognitive impairment, and mobility limitations, all of which strengthen the clinical rationale for care delivered in the home. At the same time, health systems are prioritizing alternatives to facility-based care to improve capacity management, reduce readmissions, and support recovery in familiar environments.

Digital enablement is another transformative force. Electronic health records, telehealth triage, connected medical devices, portable diagnostics, e-prescribing, and remote monitoring are making in-home clinical encounters more actionable and better integrated with broader care teams. Payment reform is also changing adoption patterns, particularly where reimbursement rewards care coordination, outcomes, and reduced avoidable utilization. However, the landscape remains constrained by clinician availability, travel-time inefficiencies, medical liability concerns, documentation burden, and variability in licensing and reimbursement rules. The next phase of house calls will favor organizations that can combine clinical rigor, route optimization, patient risk stratification, and integrated referral networks.

Cumulative Impact of Artificial Intelligence on House Calls

Artificial intelligence is having a cumulative impact on house calls by improving patient identification, care planning, operational efficiency, documentation quality, and remote monitoring. AI-enabled risk stratification can help prioritize patients who are most likely to benefit from in-home care, including individuals with frequent acute utilization, complex medication regimens, fall risk, chronic disease instability, or limited mobility. Predictive analytics can support proactive outreach, early intervention, and care escalation before avoidable deterioration occurs.

Operationally, AI can enhance scheduling, workforce allocation, travel routing, visit bundling, and supply planning, which are critical in a model where clinician time and geographic coverage strongly affect service performance. In clinical workflows, ambient documentation, natural language processing, clinical decision support, and automated coding can reduce administrative burden while improving consistency of records. AI-assisted remote patient monitoring can flag abnormal vital signs, medication nonadherence, symptom escalation, and changes in functional status. Responsible deployment remains essential: house call providers must ensure data privacy, explainability, bias monitoring, cybersecurity, human clinical oversight, and compliance with healthcare regulations. The most sustainable AI use cases are those that augment clinicians rather than replace judgment, especially in complex home environments where social context and patient preference are central to care quality.

Key Regional Insights for House Calls

Asia-Pacific is advancing house calls through a combination of rapid population aging, urban healthcare congestion, expanding digital health adoption, and large rural access gaps. Japan, South Korea, Australia, China, India, and ASEAN markets show different adoption drivers, ranging from eldercare and chronic disease management to community-based outreach and telehealth-supported home visits. Policy support for aging-in-place, growing use of remote monitoring, and rising acceptance of hybrid care models strengthen the region's long-term relevance for home-based medical services.

Europe's house calls environment is shaped by universal health coverage traditions, aging demographics, strong primary care systems, and policy emphasis on care closer to home. Countries such as the United Kingdom, Germany, France, Italy, and Spain are strengthening home and community care to relieve hospital pressure and support older adults. Regulatory standards, professional workforce models, and integration with general practice remain central to scaling.

North America remains one of the most mature regions for house calls due to value-based care programs, home-based primary care experience, advanced telehealth infrastructure, and strong demand from older adults with complex care needs. The United States is notable for policy experimentation around hospital-at-home and home-based primary care, while Canada's publicly funded systems and provincial care models support interest in home and community-based services, particularly for seniors and rural populations.

Latin America is seeing increasing relevance for house calls as health systems address uneven facility access, urban overcrowding, chronic disease burdens, and demand for convenient private healthcare. Brazil and Mexico are key examples where home visits, home diagnostics, and telehealth-supported care can help extend access, although reimbursement variability, workforce distribution, and infrastructure differences remain significant factors.

Africa's house calls landscape is defined by access needs, community health worker networks, mobile health tools, and uneven healthcare infrastructure. While physician-led home visits are less uniformly available, community-based care, maternal and child health outreach, chronic disease follow-up, and telehealth-enabled support provide practical pathways for home-based care expansion across diverse national contexts.

The Middle East is developing house call services through private healthcare growth, high chronic disease prevalence, digital health investment, and government modernization strategies. GCC countries are particularly active in smart healthcare, home nursing, and premium on-demand care models, with opportunities tied to chronic care, elderly care, and post-discharge support.

Key Group Insights for House Calls

NATO countries overlap significantly with North American and European healthcare systems, where home-based care is increasingly tied to resilience, population health management, and continuity of care. Civilian healthcare modernization, veteran and defense-related health systems, and emergency preparedness considerations all reinforce the value of distributed care models that can function outside conventional facility settings.

G7 markets generally have advanced healthcare infrastructure, aging populations, and policy interest in shifting appropriate care from hospitals to homes. House calls are supported by digital health systems, reimbursement reform, and demand for better chronic disease management. The main barriers include workforce shortages, clinician burnout, complex payment rules, and the need for measurable quality and safety outcomes.

The European Union benefits from established public health systems, cross-country policy attention to aging, and a strong emphasis on integrated care. House calls align with EU priorities around reducing avoidable hospitalization, supporting independent living, and strengthening primary care continuity. However, implementation varies across member states due to differences in reimbursement, workforce organization, and the balance between public and private provision.

BRICS countries show substantial need for scalable home-based care because of large populations, uneven healthcare access, chronic disease growth, and pressure on hospital infrastructure. China and India are particularly important due to demographic scale and digital health adoption, while Brazil and South Africa highlight the role of hybrid public-private delivery and community-based care. Russia's geographic spread reinforces the relevance of remote consultation and mobile clinical services.

ASEAN presents a diverse house calls environment where urban private healthcare demand coexists with rural and island-community access challenges. The region's expanding middle class, rising burden of noncommunicable diseases, and increasing use of digital health create opportunities for home-based consultations, chronic care follow-up, eldercare, and post-acute services. Adoption is strongest where digital payment systems, mobile connectivity, and private provider networks support convenient care delivery.

The GCC is characterized by high healthcare modernization investment, strong digital health ambitions, and demand for premium, patient-centric services. House calls in this group are supported by chronic disease management needs, expatriate population dynamics, government strategies to improve healthcare experience, and the growth of home nursing and remote monitoring. Regulatory clarity, clinician licensing, and integration with national health information systems are important enablers.

Key Country Insights for House Calls

The United States is a leading environment for house calls due to strong demand for home-based primary care, chronic disease management, palliative care, and acute care-at-home models. Value-based care arrangements, Medicare-related initiatives, remote patient monitoring reimbursement pathways, and post-discharge care needs support adoption, while staffing shortages and state-level regulatory complexity remain practical constraints. China's house calls opportunity is linked to rapid aging, high chronic disease prevalence, hospital congestion, and expanding digital health platforms, though regulatory standardization and trust in provider quality are essential. Germany's aging population, statutory insurance framework, and strong ambulatory care sector create opportunities for structured home visits, while workforce capacity and coordination between providers are key issues.

Japan has one of the world's most advanced demographic drivers for home-based medical care, with strong emphasis on aging-in-place, long-term care integration, and home medical support. India's market is shaped by large access gaps, rising urban demand, growth in home diagnostics, chronic disease needs, and mobile-first healthcare engagement. The United Kingdom has a long-standing general practice and district nursing foundation that supports home-based care, especially for frail older adults, end-of-life care, and urgent community response. France emphasizes coordinated care pathways, home hospitalization, and community-based support, making house calls relevant for post-acute, elderly, and complex care populations.

Canada's house calls landscape is shaped by provincial healthcare systems, aging demographics, rural and remote access challenges, and efforts to improve home and community care for seniors. Italy and Spain both face pronounced aging trends and hospital capacity pressures, supporting demand for home care, chronic disease monitoring, rehabilitation, and integrated primary care. Australia's vast geography, rural access needs, and established home and community care programs support house calls, especially when paired with telehealth. Brazil's large population, chronic disease burden, and uneven access to facility-based care make home-based services important, particularly when combined with community health strategies and digital tools.

South Korea's aging society, advanced connectivity, and digital health capability position it for expanded home-based care, although reimbursement and provider workflow integration remain central to broader adoption. Mexico is gaining relevance as private healthcare, urban demand for convenience, and telemedicine adoption support home visits and hybrid care models, though affordability and regional infrastructure differences influence access. Russia's geographic scale and regional disparities increase the value of mobile medical teams, telehealth, and home-based follow-up, particularly outside major urban centers.

Actionable Recommendations for House Call Leaders

Industry leaders should prioritize clinically appropriate service lines where home-based care creates measurable value, such as complex primary care, geriatric assessment, chronic disease management, post-discharge follow-up, palliative care, rehabilitation coordination, and urgent low-acuity care. Building strong referral relationships with hospitals, primary care providers, payers, long-term care facilities, and community organizations is essential to creating a reliable patient pipeline and improving continuity.

Operational excellence should focus on route optimization, clinician scheduling, standardized triage, visit protocols, portable diagnostics, medication reconciliation, and escalation pathways. Leaders should invest in interoperable digital infrastructure that connects home visits with electronic health records, telehealth, remote monitoring, e-prescribing, and care coordination tools. AI should be deployed selectively for risk stratification, documentation support, scheduling, and monitoring alerts, with governance controls for privacy, bias, clinical oversight, and cybersecurity.

To scale sustainably, providers must demonstrate outcomes using quality indicators such as hospital readmission reduction, emergency department avoidance, patient satisfaction, medication adherence, chronic disease control, functional status, and care plan completion. Workforce strategy is equally important: multidisciplinary teams that include physicians, nurse practitioners, nurses, allied health professionals, pharmacists, social workers, and community health workers can extend capacity while matching skills to patient needs. Leaders should also adapt models by geography, using dense urban routing for efficiency, hub-and-spoke networks for suburban areas, and telehealth-supported mobile teams for rural and remote communities.

Research Methodology for House Calls Analysis

This executive summary is developed using a secondary research approach grounded in publicly available, verifiable sources and established healthcare sector knowledge. The methodology considers demographic trends, healthcare delivery policies, digital health adoption, reimbursement structures, chronic disease burden, aging indicators, telehealth integration, home and community-based care models, and documented shifts toward value-based and patient-centered care.

The research framework applies qualitative analysis across regional, group, and country contexts to identify adoption drivers, barriers, and operational implications for house calls. It synthesizes evidence from health policy publications, government healthcare programs, multilateral health data, peer-reviewed literature, regulatory developments, and industry-relevant care delivery practices. The analysis deliberately avoids market sizing, market share, revenue estimation, and forecasting, focusing instead on structural demand drivers, policy signals, clinical use cases, technology impact, and strategic recommendations.

Conclusion: The Future of House Calls

House calls are becoming an increasingly important component of modern healthcare as systems seek to deliver more accessible, coordinated, and patient-centered care outside traditional facilities. Aging populations, chronic disease prevalence, hospital capacity pressures, consumer expectations, and digital health maturity are collectively strengthening the role of in-home medical services. The model is no longer limited to convenience-based visits; it is evolving into a clinically integrated approach that supports prevention, acute care substitution, post-acute recovery, palliative care, and long-term condition management.

The future of house calls will depend on evidence-based clinical governance, reimbursement alignment, multidisciplinary workforce design, and secure technology integration. Regions and countries with strong primary care systems, digital infrastructure, and policy support for care at home are best positioned to advance adoption. For industry leaders, the strategic priority is clear: build scalable, outcomes-driven, technology-enabled house call models that improve access, strengthen continuity, and deliver safe care where patients live.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. House Calls Market, by Service Modality

  • 7.1. Introduction
  • 7.2. In-Person Home Visit
  • 7.3. Hybrid Home-Based Care
  • 7.4. Virtual-Only Care

8. House Calls Market, by Care Delivery Model

  • 8.1. Introduction
  • 8.2. On-Demand Model
  • 8.3. Scheduled Episodic Model
  • 8.4. Longitudinal Model

9. House Calls Market, by Clinical Focus

  • 9.1. Introduction
  • 9.2. Primary Care
    • 9.2.1. Preventive Care
    • 9.2.2. Acute Minor Illness Management
    • 9.2.3. Medication Management
  • 9.3. Urgent Care
  • 9.4. Chronic Disease Management
  • 9.5. Post-Acute Transitional Care
  • 9.6. Behavioral Health

10. House Calls Market, by Provider Type

  • 10.1. Introduction
  • 10.2. Nurse Practitioners
  • 10.3. Physicians / Doctors
  • 10.4. Therapists
    • 10.4.1. Occupational Therapists
    • 10.4.2. Physical Therapists
    • 10.4.3. Speech Therapists

11. House Calls Market, by Age Group

  • 11.1. Introduction
  • 11.2. Pediatric Patients
  • 11.3. Adult Patients
  • 11.4. Elderly Patients

12. House Calls Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. Europe
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Africa
  • 12.6. Middle East

13. House Calls Market, by Group

  • 13.1. NATO
  • 13.2. G7
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. ASEAN
  • 13.6. GCC

14. House Calls Market, by Country

  • 14.1. United States
  • 14.2. China
  • 14.3. Germany
  • 14.4. Japan
  • 14.5. India
  • 14.6. United Kingdom
  • 14.7. France
  • 14.8. Canada
  • 14.9. Italy
  • 14.10. Australia
  • 14.11. Brazil
  • 14.12. South Korea
  • 14.13. Mexico
  • 14.14. Russia
  • 14.15. Spain

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. AccentCare, Inc.
  • 16.2. CVS Health Corporation
  • 16.3. Amedisys, Inc.
  • 16.4. Maxim Healthcare Services
  • 16.5. Interim HealthCare, Inc.
  • 16.6. Aveanna Healthcare
  • 16.7. BAYADA Home Health Care
  • 16.8. VITAS Healthcare by Chemed Corporation
  • 16.9. Addus HomeCare Corporation
  • 16.10. DispatchHealth Management, LLC
  • 16.11. BrightStar Care, LLC
  • 16.12. DocGo, Inc
  • 16.13. Doctors House Calls
  • 16.14. Elara Caring
  • 16.15. Encompass Health Corporation
  • 16.16. HarmonyCares Medical Group
  • 16.17. Home Instead, Inc.
  • 16.18. Kindred Healthcare, LLC
  • 16.19. Landmark Health, LLC
  • 16.20. LHC Group, Inc.
  • 16.21. Pager, Inc.
  • 16.22. SOS Doctors.HU
  • 16.23. UnitedHealth Group
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기